Role of RAI in the management of incidental N1a disease in papillary thyroid cancer

Following total thyroidectomy (TT) for papillary thyroid cancer (PTC), pathological assessment can occasionally reveal incidental perithyroidal lymph nodes (LNs) with occult metastases. These cN0pN1a patients often receive radioactive iodine (RAI) therapy for this indication alone. The aim of this study was to determine the central compartment nodal recurrence‐free survival in patients treated without RAI compared to those who received RAI treatment.

[1]  B. Wolffenbuttel,et al.  Thyroglobulin (Tg) recovery testing with quantitative Tg antibody measurement for determining interference in serum Tg assays in differentiated thyroid carcinoma. , 2006, Clinical chemistry.

[2]  S. Mandel,et al.  The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. , 2012, Thyroid : official journal of the American Thyroid Association.

[3]  A. Sanabria,et al.  Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer , 2011, Head & neck.

[4]  J. Griggs,et al.  Use of radioactive iodine for thyroid cancer. , 2011, JAMA.

[5]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[6]  B. Carnaille,et al.  Micrometastases in thyroid cancer. An important finding? , 2008, Surgical oncology.

[7]  I. Sugitani,et al.  A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. , 2004, Surgery.

[8]  I. Ganly,et al.  Rising incidence of second cancers in patients with low‐risk (T1N0) thyroid cancer who receive radioactive iodine therapy , 2011, Cancer.

[9]  S. Straus,et al.  Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. , 2009, Thyroid : official journal of the American Thyroid Association.

[10]  GanlyIan,et al.  Central lymph node characteristics predictive of outcome in patients with differentiated thyroid cancer. , 2014 .

[11]  J. Shah,et al.  Central lymph node characteristics predictive of outcome in patients with differentiated thyroid cancer. , 2014, Thyroid : official journal of the American Thyroid Association.

[12]  L. Akslen,et al.  Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma , 2000, Cancer.

[13]  P. Ituarte,et al.  Effect of reoperation on outcomes in papillary thyroid cancer. , 2013, Surgery.

[14]  Tae Yong Kim,et al.  The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma. , 2013, European journal of endocrinology.

[15]  Yasuhiro Ito,et al.  Clinical Significance of Lymph Node Metastasis of Thyroid Papillary Carcinoma Located in One Lobe , 2006, World Journal of Surgery.